TTHI News Alert Transition Therapeutics (TTHI) 6.85 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Transition Therapeutics (TTHI) 6.85 $TTHI

Transition Therapeutics Shares Up 23.4% Since SmarTrend's Buy Recommendation (TTHI)
Comtex SmarTrend(R) - Tue Dec 23, 5:03PM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 7 months, Transition Therapeutics has returned 23.40% as of today's recent price of $6.83.
TTHI: 6.85 (+0.02)

Shares of TTHI Up 16.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 16, 11:10AM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 16.62% as of today's recent price of $6.46.
TTHI: 6.85 (+0.02)

Direction of Market Influences: Analyst Notes on Dixie, Goodyear, Pantry, Transition Therapeutics and Turtle Beach
PR Newswire - Mon Dec 15, 11:13AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations. Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
TTHI: 6.85 (+0.02)

Is Transition Therapeutics (TTHI) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 7:31AM CST
Transition Therapeutics is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
TTHI: 6.85 (+0.02)

Transition Therapeutics Has Returned 16.0% Since SmarTrend Recommendation (TTHI)
Comtex SmarTrend(R) - Tue Dec 09, 9:30AM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 15.99% as of today's recent price of $6.42.
TTHI: 6.85 (+0.02)

Transition Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
PR Newswire - Mon Dec 08, 3:35PM CST
Transition Therapeutics Inc. ("Transition" or the "Company" (NASDAQ: TTHI, TSX: TTH) announced today that Dr. Tony Cruz, Chairman and Chief Executive Officer of Transition will be presenting at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10th, at 4:30 p.m. Eastern Time in New York City.
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)

Transition Therapeutics Up 12.2% Since SmarTrend Uptrend Call (TTHI)
Comtex SmarTrend(R) - Mon Dec 01, 5:08PM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 12.20% as of today's recent price of $6.21.
TTHI: 6.85 (+0.02)

Transition Therapeutics Shares Up 16.0% Since SmarTrend's Buy Recommendation (TTHI)
Comtex SmarTrend(R) - Mon Nov 24, 10:51AM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 15.99% as of today's recent price of $6.42.
TTHI: 6.85 (+0.02)

Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval
PR Newswire - Mon Nov 24, 5:01AM CST
Transition Therapeutics Inc. ("Transition" or the "Company" (NASDAQ: TTHI, TSX:TTH) today announced results from a thorough QT (tQT) study in which no QT effects were observed at supra-therapeutic single doses of neuropsychiatric drug candidate, ELND005. A tQT study is a specialized clinical trial required by the United States Food and Drug Administration ("FDA" for the approval of most drugs in development. Transition's wholly-owned subsidiary, Transition Therapeutics Ireland Limited ("TTIL" presented the tQT study data at the Clinical Trials in Alzheimer's Disease conference on November 21, 2014.
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)

Transition neuropsychiatric drug candidate safe in Phase 2 Down syndrome trial
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 9:55AM CST

TTHI: 6.85 (+0.02)

Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome
PR Newswire - Thu Nov 20, 5:01AM CST
Transition Therapeutics Inc. ("Transition" or the "Company" (NASDAQ: TTHI, TSX: TTH) today announced the results of a clinical study of neuropsychiatric drug candidate ELND005 in young adults with Down syndrome. Transition's wholly-owned subsidiary, Transition Therapeutics Ireland Limited ("TTIL" completed this first study in Down syndrome subjects without dementia to allow optimal dose selection for future larger studies.
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)

Transition Therapeutics EPS of -$0.45
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:45PM CST

TTHI: 6.85 (+0.02)

Transition Therapeutics Announces First Quarter Fiscal 2015 Financial Results
PR Newswire - Wed Nov 12, 3:01PM CST
Transition Therapeutics Inc. ("Transition" or the "Company" (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical development company advancing novel therapeutics for CNS and metabolic disease indications, today announced its financial results for the three month period ended September 30, 2014.
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2015 Financial Results on Wednesday, November 12th, at 4:30 P.M. EST
CNW Group - Mon Nov 10, 5:01AM CST
Transition Therapeutics Inc. ("Transition" or the "Company" (NASDAQ: TTHI, TSX: TTH) will hold a conference call on Wednesday, November 12th, 2014 at 4:30 P.M. EST to discuss First Quarter Fiscal 2015 financial results. Dr. Tony Cruz, Chairman and Chief Executive Officer of the Company, will host the call. Transition will announce its financial results for this period in a press release to be issued prior to the call. In order to participate in the conference call, please call (800) 909-7810 (North America), (416) 981-9010 (International). A replay of the conference call will be available on Transition's website www.transitiontherapeutics.com for seven days following the call.
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Lennar's 6.73% Slide Puts Disclosure Claims in Focus

Updated Category News Views 12

A homebuilder can survive ugly margins; murky demand signals are another beast entirely. Lennar is staring at a securities class action after a bruising run of disclosures and market reactions, and the central issue is not whether housing got tougher. Everybody with a pulse knew rates were squeezing buyers. The issue is whether NYSE:LEN gave investors a sufficiently clear...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 90

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
Hoymiles Brings Plug-In Solar Flexibility to RE+ 2026

Updated Category News Views 105

A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading
Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 70

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 149

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Sustainability LIVE: The Middle East Summit 2026 Insights

Updated Category News Views 218

BizClik Announces Sustainability LIVE: The Middle East Summit BizClik, the renowned global B2B media company behind the well-known Sustainability Magazine, is setting the stage for an ambitious event called Sustainability LIVE: The Middle East Summit. This summit is scheduled to take place virtually from 3-4 February 2026, providing a unique opportunity for leaders in...

Continue Reading
Bureau Veritas Ceases Discussions on Business Merger Plans

Updated Category News Views 137

Bureau Veritas Concludes Discussions on Future Collaboration In a recent declaration, Bureau Veritas disclosed that discussions surrounding a potential merger with SGS have ceased. The talks, which commenced with optimism about the potential synergies between the two leading firms in the Testing, Inspection, and Certification (TIC) industry, did not reach a conclusive...

Continue Reading
Bernstein's Insights: Why Royal Caribbean Outshines Carnival

Updated Category News Views 295

Bernstein Analyzes the Cruise Industry Landscape Recently, Bernstein analysts took a deep dive into the cruise industry, comparing two major players: Royal Caribbean (NYSE: RCL) and Carnival (NYSE: CCL). The analysts have awarded an Outperform rating to Royal Caribbean while assigning a Market-Perform rating to Carnival, based on recent assessments of the sector....

Continue Reading
NRG Energy's Impressive Q4 Performance and Exciting Future Plans

Updated Category News Views 498

NRG Energy Reports Strong Fourth Quarter Performance NRG Energy, Inc. (NYSE: NRG) has witnessed an uptick in its stock price following the announcement of its fourth-quarter results for 2024. Despite missing revenue expectations, the company demonstrated remarkable profitability. Revenue and Earnings Overview During the fourth quarter, NRG Energy reported revenues of...

Continue Reading
OpenText Introduces Cutting-Edge AI Platform for Enterprises

Updated Category News Views 317

Transforming Data Management with AI Technology OpenText has unveiled an exciting new platform that revolutionizes how enterprises manage their data. This next-generation AI Data Platform streamlines data management while incorporating innovative AI capabilities that empower organizations to activate their information securely. As the digital landscape continues to...

Continue Reading